SI
IOVA icon

Shaker Investments’s Iovance Biotherapeutics IOVA Stock Holding History

Shaker Investments’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-58,085
Closed -$430K – 99
2024
Q4 		$430K Sell
58,085
-42,627
-42% -$395K 0.18% 80
2024
Q3 		$946K Buy
100,712
+21,859
+28% +$207K 0.39% 67
2024
Q2 		$632K Sell
78,853
-234
-0.3% -$2.51K 0.28% 77
2024
Q1 		$1.17M Buy
+79,087
New +$921K 0.5% 60
2019
Q3 		– Sell
-22,850
Closed -$560K – 85
2019
Q2 		$560K Buy
+22,850
New +$344K 0.37% 59

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Shaker Investments's IOVA Position: Q1 2025 in Review

Shaker Investments sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 58,085 shares — an estimated $430K sold.

Shaker Investments first reported a position in IOVA in Q2 2019 and held it in 5 quarters. The position peaked at $1.17M in Q1 2024. 302 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

  • Shaker Investments reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Shaker Investments sold 58,085 Iovance Biotherapeutics shares in Q1 2025, an estimated $430K.
  • Shaker Investments first reported a position in Iovance Biotherapeutics in Q2 2019 and held it in 5 quarters.
  • Shaker Investments's Iovance Biotherapeutics position peaked at $1.17M in Q1 2024.
  • 302 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Shaker Investments's 13F filing for Q1 2025, filed 23 Apr 2025.